ivWatch, LLC

Have you or someone you know suffered the trauma of an IV extravasation injury? The pain and long-term impacts, both physically and emotionally, are unacceptable. Your story has the power to bring change and protect others. At ivWatch, we develop continuous IV monitoring technology to detect when fluid is leaking into the tissue instead of the vein before damage occurs. As a survivor or healthcare professional, your insight is crucial to our mission. By sharing your experience, you can help prevent others from suffering. Don't let your story go unheard. Together, we can create a future free from severe IV extravasation injuries. DM us so we can connect with you. #WorldPatientSafetyDay #PatientSafety #StopIVHarm

British Journal of Nursing (BJN) just released a new study on the immense economic impact of infiltration and extravasation injuries. The study authored by NHS IV therapy and vascular access expert Andrew Barton shows how healthcare organizations can mitigate the risks associated with IV therapy and lower the costs of these injuries with the introduction of continuous IV site monitoring technology. The article uses clinical case studies and showcases how these injuries evolve and the associated impacts on:  • Length of hospital stays  • Number of clinical procedures  • Delays in clinical care • Drug dosing errors  • Increased risk of hospital-acquired infections • Pressure on beds and medical supply usage • Increased burdens on clinical resources   Read more about the study here:  https://lnkd.in/eK4CwsM9

Andrew Barton spoke with Nursing Times on the extravasation global crisis, the clinical gap in training, the lack of awareness/recognition and how he is championing for change in IV therapy. “I’ve seen so many of these infiltration and extravasation injuries that were misdiagnosed very late on because the nurses weren’t aware of the risks and the dangers. My ambition is that every hospital will have increased safety around IV therapy administration" Read more: https://lnkd.in/ev2wA5EE

At the heart of every successful business there is a special group managing the procurement and flow of goods from beginning to end, ensuring quality products that seamlessly delivery to our external partners and customers. Susie Gahan Warren, Sophia Allen and the entire supply chain department work tirelessly with our global partners in 12 countries (and growing). Every detail matters. From early mornings and late nights, thank you for always exceeding expectations.

Mark your calendar for Thursday, December 12 at 12:00PM CST where Andrew Barton along with National Infusion Center Association (NICA) will host a CE credit webinar detailing a holistic approach to IV safety and key findings in reducing IV infiltrations and extravasations. At the culmination of the presentation Gary Warren will join for a dynamic Q&A session. Save your seat today and register here: https://lnkd.in/eGM2BQXF

Routine checks are CLEARLY not enough. In between hourly checks, this baby boy had an IV infiltrate in his foot that caused large blisters and open wounds along his heel. These severe injuries are preventable with early IV extravasation detection technology. Learn more to safeguard your patients: https://lnkd.in/eahMrbcp

Our CEO Gary Warren is this week's guest on Med Tech GURUS, the leading podcast for staying on top of the medical device industry.    Gary spoke with host Thomas Hickey about:  • How ivWatch is helping to solve the largest and most common problem in healthcare – IV therapy failures. • Our team, the heartbeat of our company, singlehandedly changing age-old clinical practices. • How we are creating a movement across the globe to help end IV extravasation injuries. Tune in and take a listen: https://lnkd.in/eAdmjKVz.

We’re live in Düsseldorf, Germany at MEDICA - Leading International Trade Fair in Hall 15.B24-1. Come stop by to meet the team and to hear about the only product in the world that can detect IV extravasations and infiltrations. Help us raise awareness about this global epidemic that we are helping to solve. Sara Brooke, Helen Stephens, Gary Warren, Erin Wendell

CONGRATS to the entire ivWatch team for bringing home first place in the Virginia Manufacturers Association "Coolest Things Made in Virginia" award. Jaclyn Lautz, Ph.D., Jesse Coburn, MBA and Susie Gahan Warren accepted the award on Friday night at the 2024 Virginia Manufacturing Cup gala.   We are extremely proud to ideate and manufacture our proprietary technology at our global headquarters in Newport News, Virginia. Only a few companies can successfully say they have the right team, the right manufacturing infrastructure, and the right place to manufacture in the USA. Our product is extremely complex, regulated, and rigorous to produce, so we brought the entire production process and talent in-house. Join us in congratulating our top-notch manufacturing, R&D, supply chain, regulatory and quality teams that all sit under one roof in Virginia. We have created a special force in the industry. This is just the beginning…   

Vesicant drugs with high or low pH levels can be extremely dangerous when administered through a peripheral IV. Imagine putting soda into your vein or even worse stomach acid and bleach. When these vesicants infiltrate, patients are at risk for severe injuries, even in the smallest amounts of fluid. Hourly checks are simply not enough. A lot can happen to your patients' IV in the 59 other minutes when you are not able to have eyes on the IV site. ivWatch technology acts as a second set of eyes, often detecting extravasations before any clinical signs or symptoms appear. • ivWatch technology 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗼𝘂𝘀𝗹𝘆 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝘀 𝗜𝗩 𝘀𝗶𝘁𝗲𝘀 𝟱𝘅 𝗽𝗲𝗿 𝘀𝗲𝗰𝗼𝗻𝗱 for IV fluid that shows up outside of the vessel. • 𝗗𝗲𝘁𝗲𝗰𝘁𝘀 𝗳𝗹𝘂𝗶𝗱 𝗶𝗻 𝗮𝘀 𝗹𝗶𝘁𝘁𝗹𝗲 𝗮𝘀 𝟬.𝟮𝗺𝗟𝘀, which is far beyond the capability of the human eye. • Notifies clinicians to act with confidence in real-time with 𝟵𝟵% 𝘀𝗲𝗻𝘀𝗶𝘁𝗶𝘃𝗶𝘁𝘆 𝗶𝗻 <𝟭𝟬 𝗺𝗟𝘀. Learn More: https://lnkd.in/eahMrbcp